Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed.

1. Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
   Review
2. Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies.Cancers · 2025
   Review
3. Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies.Frontiers in cell and developmental biology · 2021
   Review
4. Novel markers in pediatric-type follicular lymphoma.Virchows Archiv : an international journal of pathology · 2019
   Article
5. Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.Hematology/oncology clinics of North America · 2019
   Review
6. Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy.Haematologica · 2018
   Review
7. Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells.Proceedings of the National Academy of Sciences of the United States of America · 2018
   Article
8. Recent advances in understanding the biology of marginal zone lymphoma.F1000Research · 2018
   Review
9. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.Haematologica · 2017
   Article
10. Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.Leukemia · 2014
    Article
11. Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.PloS one · 2014
    Article
12. Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.PloS one · 2014
    Article
13. Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma.Mediators of inflammation · 2013
    Review
14. Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment.Leukemia · 2012
    Article
15. Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution.Infectious agents and cancer · 2012
    Article
16. Pathogenesis of human B cell lymphomas.Annual review of immunology · 2012
    Review
17. The molecular biology of diffuse large B-cell lymphoma.Therapeutic advances in hematology · 2011
    Article
18. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.Blood · 2011
    Article
19. Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models.Cell cycle (Georgetown, Tex.) · 2011
    Review
20. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development.Nature reviews. Gastroenterology & hepatology · 2010
    Review

Corrections and comments

• Comment on
  T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma.2005

Authors and funding

12 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as